Clinical Trial Update: This Study Will Evaluate the Persistence of Hepatitis A Antibodies, 8 Years and 10 Years Later, in Children Who Had Received Havrix at Selected Health Centres of Panama [NA]

View source ↗

Summary

A completed clinical trial assessing long-term persistence of Hepatitis A antibodies in children after Havrix vaccination in Panama, with results posted in 2019…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• Havrix (hepatitis A vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis A Vaccine | NA | Status: COMPLETED | Results posted: 2019-09-23